Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-01-04
DOI
10.3389/fimmu.2017.01751
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunoglobulin A: magic bullet or Trojan horse?
- (2017) Marieke H. Heineke et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- The making of bispecific antibodies
- (2017) Ulrich Brinkmann et al. mAbs
- Chickens with humanized immunoglobulin genes generate antibodies with high affinity and broad epitope coverage to conserved targets
- (2017) Kathryn H. Ching et al. mAbs
- Strategies and challenges for the next generation of antibody–drug conjugates
- (2017) Alain Beck et al. NATURE REVIEWS DRUG DISCOVERY
- Biophysical properties of the clinical-stage antibody landscape
- (2017) Tushar Jain et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2
- (2017) Krzysztof M. Zak et al. STRUCTURE
- Current progress in innovative engineered antibodies
- (2017) William R. Strohl Protein & Cell
- Distinct PD-L1 binding characteristics of therapeutic monoclonal antibody durvalumab
- (2017) Shuguang Tan et al. Protein & Cell
- HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance
- (2017) et al. Cancers
- Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab
- (2016) Zhenkun Na et al. CELL RESEARCH
- From the bench to clinical practice: understanding the challenges and uncertainties in immunogenicity testing for biopharmaceuticals
- (2016) G. R. Gunn et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Immunoglobulin Glycosylation Effects in Allergy and Immunity
- (2016) Alexandra Epp et al. CURRENT ALLERGY AND ASTHMA REPORTS
- Harnessing Fc receptor biology in the design of therapeutic antibodies
- (2016) Peter Sondermann et al. CURRENT OPINION IN IMMUNOLOGY
- Engineering antibody therapeutics
- (2016) Mark L Chiu et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?
- (2016) Alessandra Fabi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial
- (2016) Padmanee Sharma et al. LANCET ONCOLOGY
- An Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemia
- (2016) S P Koerner et al. LEUKEMIA
- Antibodies to watch in 2017
- (2016) Janice M. Reichert mAbs
- Antibody production using a ciliate generates unusual antibody glycoforms displaying enhanced cell-killing activity
- (2016) Jenny Calow et al. mAbs
- Beyond CDR-grafting: Structure-guided humanization of framework and CDR regions of an anti-myostatin antibody
- (2016) James R. Apgar et al. mAbs
- Phage display-derived human antibodies in clinical development and therapy
- (2016) André Frenzel et al. mAbs
- A Structural Perspective on the Regulation of the Epidermal Growth Factor Receptor
- (2015) Erika Kovacs et al. Annual Review of Biochemistry
- Mouse and human FcR effector functions
- (2015) Pierre Bruhns et al. IMMUNOLOGICAL REVIEWS
- Macrophages are critical effectors of antibody therapies for cancer
- (2015) Kipp Weiskopf et al. mAbs
- Mechanisms of action of therapeutic antibodies for cancer
- (2015) J.M. Redman et al. MOLECULAR IMMUNOLOGY
- Insights into the effector functions of human IgG3 in the context of an antibody targeting transferrin receptor 1
- (2015) Lai Sum Leoh et al. MOLECULAR IMMUNOLOGY
- Advances in Anticancer Immunotoxin Therapy
- (2015) C. Alewine et al. ONCOLOGIST
- Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies
- (2015) Sue Townsend et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Automated analysis of high-throughput B-cell sequencing data reveals a high frequency of novel immunoglobulin V gene segment alleles
- (2015) Daniel Gadala-Maria et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studies
- (2015) Masami Suzuki et al. Journal of Toxicologic Pathology
- Selection of IgG Variants with Increased FcRn Binding Using Random and Directed Mutagenesis: Impact on Effector Functions
- (2015) Céline Monnet et al. Frontiers in Immunology
- Antibody-Dependent Cell-Mediated Cytotoxicity Effector-Enhanced EphA2 Agonist Monoclonal Antibody Demonstrates Potent Activity against Human Tumors
- (2015) Elizabeth M. Bruckheimer et al. NEOPLASIA
- Functional Dissection of the Epidermal Growth Factor Receptor Epitopes Targeted by Panitumumab and Cetuximab
- (2015) Mareike Voigt et al. NEOPLASIA
- Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody
- (2014) Céline Monnet et al. mAbs
- Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery
- (2014) E-Chiang Lee et al. NATURE BIOTECHNOLOGY
- Next-generation antibodies
- (2014) James B. Evans et al. NATURE REVIEWS DRUG DISCOVERY
- Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice
- (2014) A. J. Murphy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates
- (2014) C. Wang et al. Cancer Immunology Research
- IgG Subclasses and Allotypes: From Structure to Effector Functions
- (2014) Gestur Vidarsson et al. Frontiers in Immunology
- Complete Haplotype Sequence of the Human Immunoglobulin Heavy-Chain Variable, Diversity, and Joining Genes and Characterization of Allelic and Copy-Number Variation
- (2013) Corey T. Watson et al. AMERICAN JOURNAL OF HUMAN GENETICS
- A Novel Investigational Fc-Modified Humanized Monoclonal Antibody, Motavizumab-YTE, Has an Extended Half-Life in Healthy Adults
- (2013) Gabriel J. Robbie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer
- (2013) Nadia Harbeck et al. Breast Care
- T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation
- (2013) Vibha Jawa et al. CLINICAL IMMUNOLOGY
- Therapeutic antibody engineering by high efficiency cell screening
- (2013) Achim Doerner et al. FEBS LETTERS
- Asymmetrical Fc Engineering Greatly Enhances Antibody-dependent Cellular Cytotoxicity (ADCC) Effector Function and Stability of the Modified Antibodies
- (2013) Zhi Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Human antibody expression in transgenic rats: Comparison of chimeric IgH loci with human VH, D and JH but bearing different rat C-gene regions
- (2013) Biao Ma et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Response to: Monoclonal antibodies targeting CD20
- (2013) Christian Klein et al. mAbs
- Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties
- (2013) Christian Klein et al. mAbs
- Myeloid cells as effector cells for monoclonal antibody therapy of cancer
- (2013) Rens Braster et al. METHODS
- New checkpoint inhibitors ride the immunotherapy tsunami
- (2013) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- GA201 (RG7160): A Novel, Humanized, Glycoengineered Anti-EGFR Antibody with Enhanced ADCC and Superior In Vivo Efficacy Compared with Cetuximab
- (2012) C. A. Gerdes et al. CLINICAL CANCER RESEARCH
- Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer
- (2012) Clara Montagut et al. NATURE MEDICINE
- Natural and man-made V-gene repertoires for antibody discovery
- (2012) William J. J. Finlay et al. Frontiers in Immunology
- Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodies
- (2011) G. Niederfellner et al. BLOOD
- HuCAL PLATINUM, a Synthetic Fab Library Optimized for Sequence Diversity and Superior Performance in Mammalian Expression Systems
- (2011) Josef Prassler et al. JOURNAL OF MOLECULAR BIOLOGY
- Human monoclonal antibodies to HIV-1 gp140 from mice bearing YAC-based human immunoglobulin transloci
- (2011) S. Pruzina et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential
- (2011) Nigel M. Stapleton et al. Nature Communications
- PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1
- (2010) M. Ghiotto et al. INTERNATIONAL IMMUNOLOGY
- Engineering Fully Human Monoclonal Antibodies from Murine Variable Regions
- (2010) Matthew J. Bernett et al. JOURNAL OF MOLECULAR BIOLOGY
- Human Framework Adaptation of a Mouse Anti-Human IL-13 Antibody
- (2010) Johan Fransson et al. JOURNAL OF MOLECULAR BIOLOGY
- B-Cell Depletion In Vitro and In Vivo with an Afucosylated Anti-CD19 Antibody
- (2010) R. Herbst et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The immunogenicity of humanized and fully human antibodies
- (2010) Fiona A. Harding et al. mAbs
- Enhanced antibody half-life improves in vivo activity
- (2010) Jonathan Zalevsky et al. NATURE BIOTECHNOLOGY
- DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
- (2010) C. Knox et al. NUCLEIC ACIDS RESEARCH
- Rapid production of recombinant human IgG With improved ADCC effector function in a transient expression system
- (2009) Patrick H.C. van Berkel et al. BIOTECHNOLOGY AND BIOENGINEERING
- Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan
- (2009) Frédéric Bibeau et al. JOURNAL OF CLINICAL ONCOLOGY
- Engineering Human IgG1 Affinity to Human Neonatal Fc Receptor: Impact of Affinity Improvement on Pharmacokinetics in Primates
- (2009) Y. A. Yeung et al. JOURNAL OF IMMUNOLOGY
- HAHA – nothing to laugh about. Measuring the immunogenicity (human anti-human antibody response) induced by humanized monoclonal antibodies applying ELISA and SPR technology
- (2009) Andreas Nechansky JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- How to systematically evaluate immunogenicity of therapeutic proteins – regulatory considerations
- (2009) Eva-Maria Jahn et al. New Biotechnology
- Cross-Interaction Chromatography: A Rapid Method to Identify Highly Soluble Monoclonal Antibody Candidates
- (2009) Steven A. Jacobs et al. PHARMACEUTICAL RESEARCH
- Design of therapeutic proteins with enhanced stability
- (2009) N. Chennamsetty et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fully human antibodies from transgenic mouse and phage display platforms
- (2008) Nils Lonberg CURRENT OPINION IN IMMUNOLOGY
- Antibody–cytokine fusion proteins: applications in cancer therapy
- (2008) Elizabeth Ortiz-Sánchez et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Antibody diversification by somatic mutation: from Burnet onwards
- (2008) Michael S Neuberger IMMUNOLOGY AND CELL BIOLOGY
- Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer
- (2008) Antonino Musolino et al. JOURNAL OF CLINICAL ONCOLOGY
- Optimization of antibody binding to Fc RIIa enhances macrophage phagocytosis of tumor cells
- (2008) J. O. Richards et al. MOLECULAR CANCER THERAPEUTICS
- Isolation of human monoclonal antibodies by mammalian cell display
- (2008) R. R. Beerli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Basis for EGF Receptor Inhibition by the Therapeutic Antibody IMC-11F8
- (2008) Shiqing Li et al. STRUCTURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started